Stockscreener 앱 받기
63.41
1.29%
0.81
시간 외 거래:
63.40
-0.010
-0.02%
전일 마감가:
$62.60
열려 있는:
$63.16
하루 거래량:
2.69M
Relative Volume:
0.57
시가총액:
$24.47B
수익:
$4.66B
순이익/손실:
$836.30M
주가수익비율:
30.30
EPS:
2.093
순현금흐름:
$1.08B
1주 성능:
+3.04%
1개월 성능:
-5.29%
6개월 성능:
-10.31%
1년 성능:
-4.40%
1일 변동 폭
$62.51
$63.87
1주일 범위
$60.82
$65.29
52주 변동 폭
$54.11
$89.98
덱스컴 Stock (DXCM) Company Profile
명칭
Dexcom Inc
전화
(858) 200-0200
주소
6340 SEQUENCE DRIVE, SAN DIEGO, CA
Compare DXCM vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DXCM
Dexcom Inc
|
63.41 | 24.16B | 4.66B | 836.30M | 1.08B | 2.093 |
ABT
Abbott Laboratories
|
91.70 | 161.12B | 45.13B | 6.28B | 7.40B | 3.5895 |
SYK
Stryker Corp
|
329.35 | 125.35B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
83.22 | 105.28B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
64.87 | 88.46B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.53 | 45.96B | 6.07B | 1.06B | 1.34B | 1.8063 |
덱스컴 Stock (DXCM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-24 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2026-01-12 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2025-12-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2025-11-25 | 개시 | Evercore ISI | In-line |
| 2025-10-21 | 재개 | Stifel | Buy |
| 2025-09-08 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2025-08-21 | 개시 | Argus | Buy |
| 2025-06-16 | 개시 | Truist | Buy |
| 2025-05-30 | 개시 | Goldman | Buy |
| 2025-04-10 | 개시 | Mizuho | Outperform |
| 2025-02-03 | 업그레이드 | Redburn Atlantic | Neutral → Buy |
| 2025-01-16 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-07-26 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-07-26 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-05-30 | 개시 | Redburn Atlantic | Neutral |
| 2024-03-12 | 개시 | RBC Capital Mkts | Outperform |
| 2023-05-30 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-04-17 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-03-29 | 개시 | UBS | Buy |
| 2023-01-26 | 개시 | Wolfe Research | Outperform |
| 2022-10-18 | 개시 | Barclays | Equal Weight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-07-15 | 개시 | Bernstein | Outperform |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-02-03 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-01-19 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-01-07 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2021-10-18 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-07-21 | 재개 | Cowen | Outperform |
| 2021-05-28 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Overweight |
| 2021-01-06 | 업그레이드 | UBS | Neutral → Buy |
| 2020-10-02 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2020-05-27 | 재확인 | Piper Sandler | Overweight |
| 2020-05-14 | 개시 | Wells Fargo | Equal Weight |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2019-11-07 | 재확인 | Canaccord Genuity | Buy |
| 2019-11-07 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2019-10-23 | 개시 | Stifel | Buy |
| 2018-11-28 | 개시 | UBS | Neutral |
| 2018-10-19 | 업그레이드 | Goldman | Sell → Neutral |
| 2018-09-12 | 업그레이드 | Northland Capital | Under Perform → Market Perform |
| 2018-08-02 | 재확인 | Canaccord Genuity | Buy |
| 2018-07-02 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2018-06-08 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-05-11 | 개시 | BofA/Merrill | Buy |
| 2018-05-03 | 재확인 | Canaccord Genuity | Buy |
| 2018-04-04 | 개시 | Goldman | Sell |
| 2018-04-04 | 개시 | Guggenheim | Neutral |
| 2018-03-23 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2018-01-04 | 다운그레이드 | Northland Capital | Market Perform → Under Perform |
| 2017-09-28 | 재확인 | Wedbush | Outperform |
모두보기
덱스컴 주식(DXCM)의 최신 뉴스
DexCom’s quarterly earnings preview: What you need to know - MSN
A Look at DexCom Inc (DXCM) After 3.1% Decline -- GF Value $109. - GuruFocus
DexCom Stock Hits Day Low of $62 Amid Price Pressure - Markets Mojo
DexCom Inc. stock outperforms competitors despite losses on the day - MarketWatch
A Look At Dexcom (DXCM) Valuation As Shares Lag And Fair Value Estimates Point Higher - Yahoo Finance
DexCom Inc. stock outperforms competitors on strong trading day - MarketWatch
Better Medical Device Stock Right Now: Abbott Laboratories vs. Dexcom - Yahoo Finance
Better Medical Device Stock Right Now: Abbott Laboratories vs. Dexcom - The Motley Fool
Devon Energy Corp stock (US2521311074): Why Google Discover changes matter more now - AD HOC NEWS
DexCom, Inc. (DXCM) Stock Analysis: Strong Buy Ratings And A 35.78% Potential Upside - DirectorsTalk Interviews
BTIG Maintains DexCom (DXCM) Buy Recommendation - MSN
DexCom Projected to Grow Profits as Q1 2026 Earnings Date Approaches - HarianBasis.co
Dexcom Inc. stock (US2521311074): Is continuous glucose monitoring strong enough to unlock new upsid - AD HOC NEWS
DexCom’s Quarterly Earnings Preview: What You Need to Know - Barchart
Devon Energy Corp stock (US2521311074): Is its shale production edge strong enough to unlock new ups - AD HOC NEWS
Lobbying Update: $75,000 of DEXCOM lobbying was just disclosed - Quiver Quantitative
TWIN CITY PRIVATE WEALTH, LLC's DexCom Inc(DXCM) Holding History - GuruFocus
DexCom, Inc. $DXCM Shares Purchased by Moran Wealth Management LLC - MarketBeat
KBC Group NV Sells 133,500 Shares of DexCom, Inc. $DXCM - MarketBeat
Chicago Capital LLC Reduces Position in DexCom, Inc. $DXCM - MarketBeat
DexCom, Inc. $DXCM Shares Purchased by Assetmark Inc. - MarketBeat
TransMedics & Dexcom: Healthcare Stocks for Long-Term GrowthNews and Statistics - IndexBox
A Look at DexCom Inc (DXCM) After 4.5% Gain -- GF Value $109.11 vs Price $63.98 - GuruFocus
Dexcom EVP Brown sells $107k in shares By Investing.com - Investing.com South Africa
Dexcom EVP Brown sells $107k in shares - Investing.com
Dexcom (DXCM) EVP sells 1,700 shares, still holds 111,204 - Stock Titan
Here's Why You Should Add DexCom Stock to Your Portfolio Now - TradingView
DexCom, Inc. $DXCM Shares Sold by Robeco Institutional Asset Management B.V. - MarketBeat
DXCM | DexCom, Inc. Executive Compensation - Quiver Quantitative
3 Reasons Investors Love DexCom (DXCM) - Barchart
DEXCOM INC ($DXCM) President & CEO 2025 Pay Revealed - Quiver Quantitative
DexCom Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
DexCom | ARS: Annual Report to Security Holders - Moomoo
[ARS] DEXCOM INC SEC Filing - Stock Titan
Dexcom (NASDAQ: DXCM) posts growth, seeks votes on board, pay and auditor - Stock Titan
Michael Brown (DXCM) files Form 144 to sell 1,700 restricted shares - Stock Titan
DexCom (DXCM) Upgraded to Buy: Here's Why - Yahoo Finance
Sumitomo Mitsui Trust Group Inc. Sells 15,977 Shares of DexCom, Inc. $DXCM - MarketBeat
DexCom, Inc. $DXCM Shares Sold by Massachusetts Financial Services Co. MA - MarketBeat
Dexcom Inc. stock (US2521311074): Why does its continuous glucose monitoring edge matter more now? - AD HOC NEWS
Dexcom Inc. stock (US2521311074): Why does its CGM leadership matter more now for U.S. investors? - AD HOC NEWS
Here's Why DexCom (DXCM) is a Strong Growth Stock - Yahoo Finance
DexCom Inc. stock underperforms Monday when compared to competitors - MarketWatch
Q4 Earnings Highs And Lows: DexCom (NASDAQ:DXCM) Vs The Rest Of The Patient Monitoring Stocks - Yahoo Finance
BTIG Research Adjusts DexCom Price Target to $80 From $85, Maintains Buy Rating - marketscreener.com
DexCom Salaries - Comparably
DexCom, Inc. (DXCM) Stock Analysis: Investors Eye A 36% Upside Potential - DirectorsTalk Interviews
Greenup Street Wealth Management Invests in DexCom - National Today
Greenup Street Wealth Management LLC Makes New Investment in DexCom, Inc. $DXCM - MarketBeat
Risk Analysis: Can DexCom Inc be the next market leader2026 Snapshot & Weekly High Return Opportunities - baoquankhu1.vn
Trend Recap: Can DexCom Inc be the next market leaderPortfolio Profit Report & High Accuracy Trade Alerts - baoquankhu1.vn
덱스컴 (DXCM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.84%
1.87%
자본화:
|
볼륨(24시간):